TP6.2.20 UK- single centre experience with the ElipseTM intragastric balloon; Early safety and effectiveness

نویسندگان

چکیده

Abstract Introduction The ElipseTM gastric balloon (EIGB) is an established outpatient, non-invasive, non-surgical device for weight-loss not requiring endoscopy nor sedation. This study reports the early safety and effectiveness from largest only reported UK cohort treated with EIGB. Methods A retrospective of 224 consecutive patients undergoing EIGB insertion between May 2018 December 2020 was performed. placement involved swallowing capsule followed by a pre-inflation abdominal radiograph to confirm position. Inflation performed 550mls sterile water post-inflation radiograph. Patients had weekly follow-up assess symptoms, weight-loss, time route expulsion. Results underwent during period; 39 were lost follow-up. 185 (28 male 157 female) included in final analysis mean age 38.1 years. Mean 10 weeks, weight at 97.7 kg. %Total Body Weight (TBW) loss 6.5% 4 weeks 9% last 32 15.3 %TBW 16 Frequently experienced symptoms first week acid reflux, pain bloating, nausea vomiting. One patient expulsion 8 weeks. Seven required deflation due severe (5), pancreatitis (1) hyperinflation (1). Conclusion safe effective method loss. Longer studies population are overall outcomes associated factors

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients.

BACKGROUND The temporary use of the BioEnterics Intragastric Balloon (BIB) in morbidly obesity is increasing worldwide. The aim of this study is the evaluation of the efficacy of this device in a large population, in terms of weight loss and its influence on co-morbidities. METHODS Data were retrospectively recruited from the data-base of the Italian Collaborative Study Group for Lap-Band and...

متن کامل

Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis.

BACKGROUND Intragastric balloons have been used since 1985 to treat obesity, but an evidence-based systematic review had not been previously performed. The objective of this study is to determine the safety, efficacy, and effectiveness of the most widely used balloon, BioEnterics Intragastric Balloon (BIB), to treat obesity. METHODS Systematic literature review of Medline, Embase, and other i...

متن کامل

Comprehensive cardiovascular MRI in hypertension: a UK single centre experience

Background MRI is a useful investigation in hypertensive patients, providing a non-invasive method for the assessment of the heart and potential secondary causes (including adrenal, aortic, renal and renovascular abnormalities). This is now more relevant with the introduction of therapies such as renal denervation in those with suitable anatomy. The ability to perform a single comprehensive ass...

متن کامل

Long-term effectiveness of BioEnterics intragastric balloon in obese patients.

BACKGROUND/AIMS The BioEnterics intragastric balloon has been considered an effective and less invasive method for weight loss. This study aimed to evaluate the effect of this method on long-term weight loss. MATERIAL AND METHODS From June 2009 to June 2011, 32 patients (14 male, 18 female) underwent BioEnterics intragastric balloon therapy for 6 months. The mean age of the subjects was 39,7±...

متن کامل

Management of Perinatal Testicular Torsion: A Single Centre Experience

Perinatal testicular torsion (PTT) is a rare entity. The management of PTT is controversial, due to the low viability of the testis and the possibility of bilateral torsion. This is a review of our experience with six cases of PTT, highlighting diagnostic and therapeutic difficulties of this condition.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: British Journal of Surgery

سال: 2021

ISSN: ['1365-2168', '0007-1323']

DOI: https://doi.org/10.1093/bjs/znab362.047